Business & Investment

Why Oxford Nanopore Shares Are Falling Rapidly

NS Oxford Nanopore (LSE: ONT) Stock prices are falling. At the IPO on September 30, the stock was valued at 425p. Then, the next day, it jumped 50% to 615p. However, in the last two weeks, stock prices have fallen to 548p. Yes, some early investors are making a profit. But what else is happening?

business model

The company has “”Developed a new generation of sensing technology using nanopores It is built into high-tech electronics to perform accurate molecular analysis. “ In plain English, it is the market leader in DNA and RNA sequencing technology. The company has developed a product that analyzes DNA by passing a DNA sample through a small hole (nanopore) and measuring its response to an electric current.

One killer stock for cybersecurity surges

Cybersecurity is skyrocketing and experts say Cybersecurity market will reach US $ 366 billion by 2028 — — More than double today!

And with such growth, this North American company will be the biggest winner.

Because their patented “self-healing” technology is changing the outlook for cybersecurity, as we know it …

We believe it could be the next well-known technology success story.In fact, we think it could be just as big … or Bigger than Shopify.

Click here to find out how to identify the name of this North American stock It’s taking over Silicon Valley on one device at a time …

Its main product minionIs the only portable real-time DNA / RNA sequencer on the market. There are currently dozens of applications including virus identification, Ebola monitoring, environmental tracking, antibiotic resistance monitoring, food safety monitoring, cancer analysis, agricultural development, fetal DNA analysis and more.

This technology can also be used to monitor air conditioning and check for pathogens at the airport. In addition, because it is convenient to carry, it is useful not only for doctors who visit patients at home, but also for emergency medical care in ambulances. The possibilities for the future are endless, and the potential for significant revenue generation is very real. You can understand why the stock price soared first.


Prior to the IPO, Oxford Nanopore revenues increased from £ 52m in 2019 to £ 113.9m in 2020. This is primarily due to a government contract for a coronavirus test kit that supports the pandemic effort. But even though the company has almost doubled its revenue, it hasn’t made a profit yet. However, as a growth stock, it is not uncommon to invest income in R & D. Also, some investors seem ready to wait for the company to make a profit, as profits may increase in the future.

But with this Current inflationary environment, Interest rates are about to rise. So for now, I think deficit growth stocks are particularly vulnerable. Analysts do not expect the company to achieve profitability until 2026. Still, there is no guarantee. According to the latest figures, Oxford Nanopore generated £ 59m in revenue and lost £ 44.4m in the first half of this year.

On the plus side, CEO Gordon Sanghera manages special shares to deny unwanted acquisitions over the next three years. This means that biotechnology companies will not be subject to hostile takeovers during their expansion phase. This is attractive to me as a long-term investor.

My Verdict on Oxford Nanopore Stock Price

Oxford Nanopore’s share price remains 30% higher than the IPO two weeks ago. But I think part of this rise is due to investors being overly excited about the rare UK biotechnology listing. And I believe the technology could soon be replicated elsewhere. I ignore the stock price of Oxford Nanopore because the profit seems to be a few years away. It may be revolutionary, but I’m worried about the company’s financial outlook due to monetary tightening.

Is this lesser-known company the next “monster” IPO?

Now this “Scream and buy” Stocks are trading at a significant discount from the IPO price, but the sky seems to be the limit for the next few years.

This North American company is presumed to be a clear leader in the field. Equivalent to US $ 261 billion by 2025..

The Motley Fool UK team of analysts has published a comprehensive report that explains exactly why we believe it has tremendous potential.

But I warn you, You need to act quicklyConsidering how fast this “Monster IPO” is already moving.

Click here to find out how to get a copy of this report yourself today

Charles Archer There are no positions in any of the listed shares. Motley Fool UK does not have a position in any of the listed shares. The views expressed about the companies mentioned in this article are those of the author and may differ from the official recommendations made by subscription services such as Share Advisor, Hidden Winners, and Pro. Here at The Motley Fool, by exploring different insights, Better investors than us.

Why Oxford Nanopore Shares Are Falling Rapidly Why Oxford Nanopore Shares Are Falling Rapidly

Back to top button